Senate HELP Committee Members Slam Moderna’s CEO for Instituting Nearly 500 Percent Price Increase on Company’s COVID-19 Vaccine On Wednesday, the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) held a hearing with Moderna’s CEO, Stéphane Bancel, titled “Taxpayers Paid Billions For It: So Why Would Moderna Consider Quadrupling the Price of the
Senate HELP Committee Hearing with Moderna CEO Offers Prime Opportunity to Push Back on Brand Name Drug Company Profiteering Ahead of Shift to Commercial Distribution For Immediate Release Contact:…
Senate HELP Committee to Question Moderna CEO on Nearly 500 Percent Price Hike on COVID-19 Vaccine Developed with Taxpayer Investment As COVID-19 vaccine and therapeutic coverage shifts to the…
Big Pharma Giants With Affinity for Price Hikes Acquire Smaller Brand Name Drug Companies with Their Own History of Egregious Pricing Practices This week, two Big Pharma giants, both…
Wall Street Journal Analysis Finds Median Monthly Price for Newly Approved Drugs Nearly Tripled in 10 Years, from $2,624 in 2011 to $7,034 in 2022 A new analysis released this week by The Wall…
Event Highlights Importance of Holding Big Pharma Accountable to Boost Competition and Lower Drug Prices In case you missed it, on Thursday, The Hill hosted a virtual event…
More Big Pharma Companies Should Also Lower Their Insulin Prices, But Policymakers Must Address Root Cause of High Drug Prices To Secure Lasting Relief For Immediate ReleaseContact: Jon…
Anti-Competitive Strategy Around Brand Name Narcolepsy Medications Blocked Patients from Accessing Alternatives In case you missed it, on Tuesday, The New York Times reported on anti-competitive…
Big Pharma Giants Once Again Top Wall Street Expectations in Final Round of Fourth Quarter Earnings Reports While Continuing to Price-Gouge American Patients A final round of Big Pharma 2022…
Four Big Pharma Giants That Hiked Drug Prices on American Patients in 2022 and First Weeks of 2023 All Beat Wall Street Earnings Expectations Another round of fourth-quarter earnings reports from…